Target intelligence / Profile preview

Cellular communication network factor 2 (CCN2)

Target
CCN2
Molecular classification
Matricellular protein, Growth factor, Extracellular matrix protein, Other
01

Overview

Cellular communication network factor 2 (CCN2), historically known as connective tissue growth factor (CTGF), is a cysteine-rich, secreted matricellular protein belonging to the CCN family. It plays a pivotal role in coordinating cellular responses to the extracellular matrix by interacting with various cell surface receptors, including integrins, heparan sulfate proteoglycans (HSPGs), and low-density lipoprotein receptor-related proteins (LRPs), as well as growth factors like TGF-beta and VEGF. CCN2 is a critical mediator of tissue remodeling, wound healing, and fibrogenesis, and its aberrant overexpression is strongly associated with progressive fibrotic diseases (such as idiopathic pulmonary fibrosis and diabetic nephropathy), cardiovascular diseases, and various malignancies. Consequently, CCN2 has been a major therapeutic target for anti-fibrotic drug development. Therapeutic strategies have included monoclonal antibodies (e.g., pamrevlumab), RNA interference therapeutics (e.g., RXI-109), and inhaled Anticalin proteins (e.g., PRS-220). However, clinical translation has faced significant hurdles, with systemic inhibitors like pamrevlumab failing in Phase III trials for idiopathic pulmonary fibrosis and Duchenne muscular dystrophy, often attributed to poor tissue penetration and target-mediated drug disposition.

Other names
Connective tissue growth factorCTGFCCN family member 2Hypertrophic chondrocyte-specific protein 24HCS24Insulin-like growth factor-binding protein 8IGFBP8NOV2
02

Mechanism of action

Monoclonal antibody binding to the von Willebrand factor type C (vWC) domain of CTGF, preventing its interaction with TGF-beta and other cytokines; RNA interference (RNAi) mediated knockdown of CTGF mRNA to reduce protein expression; Anticalin protein binding and neutralizing extracellular CTGF; Aptamer binding to the C-terminal (CT) domain of CTGF to inhibit its fibrotic activity.

03

Biological functions

Cell adhesionCell migrationCell proliferationAngiogenesisSkeletal developmentTissue wound repairExtracellular matrix productionSignal transductionOther
04

Disease associations

FibrosisCancerCardiovascular diseaseDiabetic nephropathyDiabetic retinopathyOphthalmic diseaseDuchenne muscular dystrophyOther
05

Safety considerations

Target-mediated drug disposition (TMDD) leading to rapid clearance and poor tissue penetrationPotential impairment of normal wound healing and skeletal homeostasisLack of efficacy in systemic administration (as seen in Phase III failures of pamrevlumab for IPF and DMD)
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Forced vital capacity (FVC)Serum CTGF/CCN2 levelsQuantitative high-resolution computed tomography (HRCT) lung fibrosis scoresAlpha-smooth muscle actin (alpha-SMA) expressionCollagen levels

Beyond the preview

Go deeper on Cellular communication network factor 2 (CCN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular communication network factor 2 (CCN2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call